Coronavirus (COVID-19) FDA Updates
May 31, 2020

The U.S. Food and Drug Administration today continued to take action in the ongoing response to the COVID-19 pandemic: MyStudies app is now available to investigators as a free platform to obtain informed consent securely from patients for eligible clinical trials.

Through the COVID MyStudies app, the investigator can send the informed consent document electronically to the patient or his or her legally authorized representative. Once the patient or representative has signed the form, he or she will receive an electronic copy. The investigator can then access the signed consent in a secure manner and print it or transfer the file electronically.

More info here